Pediatric Implantable Port Market Size, Share, Growth, and Industry Analysis, By Type (Titanium Port Body, Plastic Port Body), By Application (Cancer, End-Stage Renal Disease, Diabetes), Regional Forecast To 2034

• 

  Request a Free sample to learn more about this report

PEDIATRIC IMPLANTABLE PORT MARKET OVERVIEW

The global pediatric implantable port market size was valued at USD 0.099 billion in 2025 and is expected to reach USD 0.165 billion by 2034, growing at a compound annual growth rate (CAGR) of about 5.89% from 2025 to 2033.

The United States pediatric implantable port market size is projected at USD 0.031 Billion in 2025, the Europe pediatric implantable port market size is projected at USD 0.023 Billion in 2025, and the China pediatric implantable port market size is projected at USD 0.031 Billion in 2025.

A pediatric implantable port is a medical device that is implanted under the skin of a child to provide long-term access to the bloodstream for administering medications, blood products, or parenteral nutrition. It is typically used in children who require frequent or long-term intravenous therapy, such as chemotherapy, hemodialysis, or immune globulin therapy.

The port consists of a small metal or plastic chamber, called the reservoir or the portal that is placed under the skin, usually in the chest or upper arm. The reservoir is connected to a catheter, which is inserted into a large vein, such as the subclavian or jugular vein, and threaded into the superior vena cava, which is a large vein that carries blood to the heart. Because of the rising frequency of chronic illnesses in children, increased demand for less invasive operations, port device technical developments and the need for improved and effective drug delivery methods, the pediatric implantable port market is predicted to develop internationally.

KEY FINDINGS

COVID-19 IMPACT

Pandemic Decreased the Market Demand 

The pandemic has caused supply chain interruptions, decreased demand for non-urgent surgeries, and clinical trial delays, all of which have impacted the pediatric implantable port industry. Many non-urgent procedures, including implantable port placements, were postponed or cancelled as hospitals and healthcare facilities prioritized COVID-19 patients. Many parents have been hesitant to bring their children to healthcare facilities for fear of infection, resulting in a decrease in patient volume for pediatric implanted port operations. Because of the pandemic, worldwide supply chains have been interrupted, resulting in shortages of various medical devices and equipment, including implanted ports. Due to limits on in-person visits and patient enrollment, clinical studies for novel implanted port devices have been delayed. Despite these obstacles, the pediatric implantable port market is expected to recover as the healthcare sector improves.

LATEST TRENDS

Rising Prevalence of Chronic Diseases to Fuel Market Growth

A medical device that is placed under the skin and used for long-term intravenous (IV) therapy is known as an implantable port. The pediatric implanted port market is a subset of the wider implantable port business that is targeted exclusively at children. The need for pediatric implantable ports has progressively increased in recent years as the number of children requiring long-term IV treatments has increased. This is due to an increase in chronic disorders including cancer, haemophilia, and cystic fibrosis, among others. Pediatric implanted ports have grown in popularity because to their simplicity of use, decreased infection rates, and increased quality of life for children. Companies are concentrating on developing smaller and more comfortable port devices for youngsters, which would increase patient comfort and satisfaction. Telemedicine and remote monitoring technologies have also acquired commercial momentum, allowing healthcare practitioners to remotely monitor patients and eliminate the need for in-person visits.

• According to the CDC’s 2023 HAI Progress Report, CLABSI rates in acute care hospitals fell by 13% between 2022 and 2023 (ICU: 20%; NICU: 13%; wards: 8%)

• According to the CDC, MRSA bloodstream events declined by 16% nationally between 2022 and 2023

Request a Free sample to learn more about this report

PEDIATRIC IMPLANTABLE PORT MARKET SEGMENTATION

By Type Analysis

According to type, the market can be segmented into titanium port body, plastic port body.

By Application Analysis

Based on service, the market can be divided into cancer, end-stage renal disease, diabetes.

DRIVING FACTORS

Improvement in Healthcare Infrastructure to Accelerate Market Demand

Chronic disorders such as cancer, cystic fibrosis, and sickle cell disease sometimes necessitate frequent and long-term intravenous therapy in children. Implantable ports enable dependable and convenient access to veins, eliminating the need for several needle jabs. Because to the advancement of smaller and more sophisticated implanted ports, the operation has become safer and more efficient, lowering the risk of problems. Implantable ports need only a minor surgical operation, lowering complications and recuperation time. This has enhanced their appeal among doctors and patients alike. Advances in healthcare infrastructure, particularly in emerging nations, have boosted pediatric patients' access to implanted ports. These factors are accelerating pediatric implantable port market growth.

• According to the National Cancer Institute, an estimated 9,550 new pediatric cancer cases will be diagnosed in 2025, necessitating long‑term vascular access.

• According to SEER data, 5‑year relative survival for childhood leukemia reached 86.3% (2015–2021), increasing demand for durable ports.

Growing Awareness about Healthcare Advanced Equipment to Fuel Market Growth

The port consists of a small metal or plastic chamber, called the reservoir or the portal that is placed under the skin, usually in the chest or upper arm. The reservoir is connected to a catheter, which is inserted into a large vein, such as the subclavian or jugular vein, and threaded into the superior vena cava, which is a large vein that carries blood to the heart. Because of the rising frequency of chronic illnesses in children, increased demand for less invasive operations, port device technical developments and the need for improved and effective drug delivery methods, the pediatric implantable port market is predicted to develop internationally.

RESTRAINING FACTORS

High Cost and Complications to Hinder Growth of Market

Pediatric implantable ports are costly devices that may not be available to all patients. This may limit their acceptance, particularly in underdeveloped nations. Complications from implantable ports include infection, thrombosis, and catheter dislodgement. These consequences may necessitate extra medical procedures, raising healthcare expenses and causing patient suffering.

• According to the CDC, despite reductions, an estimated 30,100 CLABSIs still occur annually in U.S. acute care facilities

• According to FDA guidance, implantable ports in children have an estimated service life of 2 to 6 years, requiring eventual replacement

• Request a Free sample to learn more about this report

•  

PEDIATRIC IMPLANTABLE PORT MARKET REGIONAL INSIGHTS

Advanced Healthcare Infrastructure in North America Anticipated to Boost Market Development

North America holds the leading position in pediatric implantable port market share due to the presence of a large number of pharmaceutical companies, children's high prevalence of chronic disorders, well-established healthcare infrastructure, and favorable reimbursement policies and growing understanding among healthcare practitioners of the advantages of implantable ports.

KEY INDUSTRY PLAYERS

Market Growth is being influenced by Adoption of Innovative Strategies by Key Players

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio.

The top key players in the market are C.R. Bard, AngioDynamics, Smiths Medical, B. Braun, Teleflex, Cook Medical, Fresenius Kabi, PFM Medical, Vygon, Districlass, Navilyst, PakuMed. The strategies to develop new technologies, capital investment in R&D, improve product quality, acquisitions, mergers, and compete for the market competition help them to perpetuate their position and value in the market. Besides, collaboration with other companies & extensive possession over market shares by the key players stimulates market demand.

• C.R. Bard: Holds approximately 20% of the implantable‑port market

• AngioDynamics: Accounts for about 15% of market share

List of Top Pediatric Implantable Port Companies

• Districlass
• C.R. Bard
• Fresenius Kabi
• Cook Medical
• Smiths Medical
• PakuMed
• Vygon
• PFM Medical
• B. Braun
• Navilyst
• Teleflex
• AngioDynamics

REPORT COVERAGE

This report examines an understanding of the pediatric implantable port market’s size, share, and growth rate, segmentation by type, application, key players, and previous and current market scenarios. The report also collects the market’s precise data and forecasts by market experts. Also, it describes the study of this industry’s financial performance, investments, growth, innovation marks, and new product launches by the top companies and offers deep insights into the current market structure, competitive analysis based on key players, key driving forces, and restraints that affect the demand for growth, opportunities, and risks.

Furthermore, the post-COVID-19 pandemic’s effects on international market restrictions and a deep understanding of how the industry will recover, and strategies are also stated in the report. The competitive landscape has also been examined in detail to provide clarification of the competitive landscape.

This report also discloses the research based on methodologies that define price trend analysis of target companies, collection of data, statistics, target competitors, import-export, information, and previous years’ records based on market sales. Moreover, all the significant factors which influence the market such as small or medium business industry, macro-economic indicators, value chain analysis, and demand-side dynamics, with all the major business players have been explained in detail. This analysis is subject to modification if the key players and feasible analysis of market dynamics change.